LeMaitre Vascular, Inc. (LMAT) Draws Bullish Attention After Forming Bullish Wedge Up Pattern

September 16, 2018 - By Jimmy Baldridge

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Logo

Investors sentiment increased to 2.41 in Q2 2018. Its up 0.99, from 1.42 in 2018Q1. It is positive, as 11 investors sold LeMaitre Vascular, Inc. shares while 28 reduced holdings. 32 funds opened positions while 62 raised stakes. 14.96 million shares or 9.18% more from 13.70 million shares in 2018Q1 were reported.
Piedmont Invest Advsrs Ltd invested in 3,564 shares. Rice Hall James And Assoc Limited Liability holds 58,491 shares or 0.07% of its portfolio. State Teachers Retirement System owns 13,489 shares for 0% of their portfolio. Parametric Port Ltd Limited Liability Company invested in 28,238 shares or 0% of the stock. 128,820 were accumulated by Aqr Management Ltd Liability Corp. Citigroup accumulated 2,066 shares or 0% of the stock. Td Asset Mngmt Inc owns 11,600 shares or 0% of their US portfolio. Qs Ltd Limited Liability Company reported 7,188 shares. Secor Advisors Lp holds 28,234 shares. Epoch Inv Ptnrs holds 932,093 shares or 0.1% of its portfolio. Sei Investments Company owns 3,985 shares or 0% of their US portfolio. Jpmorgan Chase has 0% invested in LeMaitre Vascular, Inc. (NASDAQ:LMAT) for 11,356 shares. Deutsche Bank & Trust Ag has invested 0% in LeMaitre Vascular, Inc. (NASDAQ:LMAT). Mason Street Ltd Liability Corp accumulated 0% or 4,406 shares. Envestnet Asset Mngmt stated it has 6,121 shares.

Since May 7, 2018, it had 0 buys, and 10 selling transactions for $6.57 million activity. On Monday, May 21 the insider LeMaitre George W sold $1.47M. Pellegrino Joseph P JR sold 501 shares worth $18,552. Another trade for 1,000 shares valued at $34,000 was sold by Jasinski Lawrence J.

The stock of LeMaitre Vascular, Inc. (LMAT) formed an up wedge with $37.81 target or 9.00 % above today’s $34.69 share price. The 9 months wedge indicates low risk for the $675.14 million company. If the $37.81 price target is reached, the company will be worth $60.76M more.
Rising wedges, especially for downward breakouts are tricky moments to trade. Investors must be aware that the break even failure rate for up or down breakouts is: 8% and 24%. The average rise is 28% and the decline is 14%. Wedges has high throwback and pullback rate: 73%, 63% and the percent of wedges meeting target is not more than 50%.

The stock decreased 0.26% or $0.09 during the last trading session, reaching $34.69. About 93,473 shares traded. LeMaitre Vascular, Inc. (NASDAQ:LMAT) has declined 9.94% since September 16, 2017 and is downtrending. It has underperformed by 25.56% the S&P500.

Analysts await LeMaitre Vascular, Inc. (NASDAQ:LMAT) to report earnings on October, 25. They expect $0.21 earnings per share, down 16.00 % or $0.04 from last year’s $0.25 per share. LMAT’s profit will be $4.09 million for 41.30 P/E if the $0.21 EPS becomes a reality. After $0.43 actual earnings per share reported by LeMaitre Vascular, Inc. for the previous quarter, Wall Street now forecasts -51.16 % negative EPS growth.

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Ratings Coverage

Among 4 analysts covering LeMaitre Vascular (NASDAQ:LMAT), 2 have Buy rating, 0 Sell and 2 Hold. Therefore 50% are positive. LeMaitre Vascular had 4 analyst reports since April 26, 2018 according to SRatingsIntel. The rating was maintained by Canaccord Genuity with “Hold” on Monday, July 9. Stifel Nicolaus downgraded the stock to “Hold” rating in Thursday, April 26 report. The stock of LeMaitre Vascular, Inc. (NASDAQ:LMAT) has “Buy” rating given on Thursday, April 26 by Benchmark.

Another recent and important LeMaitre Vascular, Inc. (NASDAQ:LMAT) news was published by Globenewswire.com which published an article titled: “LeMaitre Vascular to Present at Upcoming Investor Conferences” on September 07, 2018.

LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. The company has market cap of $675.14 million. The firm offers angioscope, a fiber optic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to temporarily perfuse the blood and other fluids into the vasculature. It has a 32.12 P/E ratio. It also provides carotid shunts that temporarily shunt the blood to the brain during the removal of plaque from the carotid artery in a carotid endarterectomy surgery; powered phlebectomy devices to remove varicose veins; and radiopaque tape, a medical-grade tape applied to the skin that enables interventionists to cross-refer between the inside and the outside of a patient's body, and allows them to locate tributaries or lesions beneath the skin.

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: